Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand

15Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

New Zealand (NZ) is one of few countries to shift from PCV13 to PCV10. The number of serotype 19A cases in young children and the proportions of isolates that are penicillin-resistant have been steadily increasing since. It is time for NZ to reconsider its choice of pneumococcal vaccine.

Cite

CITATION STYLE

APA

Anglemyer, A., Mcneill, A., Dubray, K., Sonder, G. J. B., & Walls, T. (2022). Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand. Clinical Infectious Diseases, 74(10), 1859–1861. https://doi.org/10.1093/cid/ciab766

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free